GRDX Q1 2026 Earnings PreRevenue Stage with Widening Losses TDOC Q1 2026 Earnings EPS Misses Expectations as Teladoc Reports WiderThanAnticipated Loss JJSF Q1 2026 Earnings EPS Misses Estimates Despite Narrow Surprise Stock Edges Higher CASS Q1 2026 Earnings EPS Beats Estimates by Nearly 6 Stock Edges Lower AIXC Q3 2023 Earnings Significant EPS Beat Despite Net Loss Fulcrum Therapeutics FULC Edges Higher as Biotech Sentiment Stabilizes VCI Global VCIG Skyrockets 6479 Surge Tests Key Resistance at 140 ADMA Biologics Slides 109 Key Support Levels in Focus Amid Biotech Headwinds Xperi Inc XPER Edges Higher A Cautious Recovery from Support Levels NexPoint Real Estate Finance Inc Q1 2026 Earnings EPS Surpasses Estimates by 129 Stock Declines